Literature DB >> 1387414

Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.

W Chen1, E A Havell, L L Moldawer, K W McIntyre, R A Chizzonite, A G Harmsen.   

Abstract

The importance of endogenous interleukin 1 (IL-1) in resistance to Pneumocystis carinii infection was examined in a SCID mouse model. Naturally acquired pulmonary infection of P. carinii in SCID mice was completely cleared by reconstitution of the infected mice with immunocompetent spleen cells. IL-1 activity in the lung homogenate supernatant of these mice increased significantly after reconstitution and returned to baseline level after the clearance of P. carinii. Treatment of reconstituted SCID mice with 35F5, a monoclonal antibody against murine type I IL-1R almost completely inhibited the clearance of P. carinii. In contrast, treatment with control rat immunoglobulin G had no detectable effect. Further study revealed that for the complete clearance of P. carinii, IL-1 must be present at the early stage of immune responses induced by reconstitution, since clearance could be blocked by a single injection of 35F5 into SCID mice at 2 d, but not at either 8 or 13 d postreconstitution. Furthermore, pulmonary recruitment of neutrophils, macrophages, and lymphocytes was significantly inhibited in mice that received 35F5 treatment. These findings strongly suggest that, in reconstituted SCID mice, endogenous IL-1 is important in host resistance to P. carinii infection and that IL-1 may function early in the host response possibly by the recruitment of inflammatory cells into the lungs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387414      PMCID: PMC2119343          DOI: 10.1084/jem.176.3.713

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Two high-affinity interleukin 1 receptors represent separate gene products.

Authors:  R Chizzonite; T Truitt; P L Kilian; A S Stern; P Nunes; K P Parker; K L Kaffka; A O Chua; D K Lugg; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 2.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.

Authors:  J Shellito; V V Suzara; W Blumenfeld; J M Beck; H J Steger; T H Ermak
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

4.  Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.

Authors:  W Chen; E A Havell; A G Harmsen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor.

Authors:  R A Ezekowitz; D J Williams; H Koziel; M Y Armstrong; A Warner; F F Richards; R M Rose
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  Type I IL-1 receptor blockade exacerbates murine listeriosis.

Authors:  E A Havell; L L Moldawer; D Helfgott; P L Kilian; P B Sehgal
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

7.  Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro.

Authors:  E L Pesanti
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

8.  Analysis of the developmental stages of Pneumocystis carinii, in vitro.

Authors:  M T Cushion; J J Ruffolo; P D Walzer
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

9.  In-vitro interaction of human macrophages with Pneumocystis carinii.

Authors:  M Forte; M Rahelu; C Stubberfield; L Tomkins; A Pithie; D Kumararatne
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

10.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

Review 3.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 4.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

5.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

Authors:  S A Theus; D W Sullivan; P D Walzer; A G Smulian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Interleukin-1 is involved in mouse resistance to Mycobacterium avium.

Authors:  M Denis; E Ghadirian
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii.

Authors:  O Kandil; J A Fishman; H Koziel; P Pinkston; R M Rose; H G Remold
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Authors:  S A Theus; M J Linke; R P Andrews; P D Walzer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

Authors:  C B Faulkner; J W Simecka; M K Davidson; J K Davis; T R Schoeb; J R Lindsey; M P Everson
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.